NTLA Operating Cash Flow (Statement)
Intellia Therapeutics Inc · Operating Cash Flow (Statement)
NTLA Operating Cash Flow (Statement)
Latest reported-$346.64Mperiod ending
NTLA TTM Cash from Operations (-$1.76M → -$346.64M)
TTM operating cash flow (statement)
High-resolution chart · PNG
NTLA operating cash flow (statement) history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -346,643,000 | |
| -363,152,000 | |
| -394,736,000 | |
| -410,646,000 | |
| -418,584,000 | |
| -377,148,000 | |
| -348,880,000 | |
| -356,739,000 | |
| -373,283,000 | |
| -405,420,000 | |
| -394,086,000 | |
| -390,901,000 | |
| -368,046,000 | |
| -362,814,000 | |
| -333,287,000 | |
| -298,069,000 | |
| -284,565,000 | |
| -252,455,000 | |
| -225,030,000 | |
| -210,605,000 | |
| -174,141,000 | |
| -63,743,000 | |
| -49,912,000 | |
| -38,348,000 | |
| -35,238,000 | |
| -120,332,000 | |
| -103,240,000 | |
| -83,116,000 | |
| -70,122,000 | |
| -64,940,000 | |
| -61,257,000 | |
| -74,025,000 | |
| -78,465,000 | |
| -71,648,000 | |
| -65,276,000 | |
| -58,380,000 | |
| -49,096,000 | |
| 34,132,000 | |
| 36,109,000 | |
| 45,028,000 | |
| 49,371,000 | |
| -16,006,000 | |
| -1,763,000 | |
| 994,000 | |
| 4,257,000 |